Corvus Pharmaceuticals, Inc. (CRVS) Social Stream



Corvus Pharmaceuticals, Inc. (CRVS): $0.74

-0.04 (-5.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRVS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

CORVUS PHARMACEUTICALS INC (CRVS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRVS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $6 $3.5 $5.125 $0.79 548.73%
2021-12-01 5 $8 $3.5 $5.7 $0.79 621.52%
2021-12-03 5 $8 $3.5 $6.3 $0.79 697.47%
2022-05-11 2 $8 $6 $7 $0.79 786.08%
2022-08-09 3 $8 $4 $6 $0.79 659.49%

The Trend in the Analyst Price Target


CRVS's average price target has moved down $2.6 over the prior 28 months.

CRVS reports an average of 258.81% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-01 5 8 3.5 5.700 3.27 74.31%
2021-12-03 4 8 3.5 6.300 3.10 103.23%
2021-12-03 3 8 3.5 6.375 3.10 105.65%
2022-05-11 2 8 6.0 7.333 1.10 566.64%
2022-05-11 2 8 3.5 6.375 1.10 479.55%

CRVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


CRVS's average broker recommendation rating improved by 0.5 over the prior 35 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, CORVUS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 951.51% of them.
  • To contextualize these metrics, consider that out of all US stocks, CORVUS PHARMACEUTICALS INC's average analyst price target is greater than 49.27% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, CORVUS PHARMACEUTICALS INC's number of analysts covering the stock is higher than 189.77% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, CORVUS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -552.52% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CORVUS PHARMACEUTICALS INC are CRNX, CRMD, and CRBP.

What is the outlook for CRVS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5072 seconds.